Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cogent Biosciences (COGT) Preferred Stock Liabilities: 2017-2020

Historic Preferred Stock Liabilities for Cogent Biosciences (COGT) over the last 2 years, with Dec 2020 value amounting to $110.9 million.

  • Cogent Biosciences' Preferred Stock Liabilities fell 38.22% to $85.4 million in Q3 2021 from the same period last year, while for Sep 2021 it was $85.4 million, marking a year-over-year decrease of 38.22%. This contributed to the annual value of $110.9 million for FY2020, which is N/A change from last year.
  • Latest data reveals that Cogent Biosciences reported Preferred Stock Liabilities of $110.9 million as of FY2020, which was up 43.72% from $77.2 million recorded in FY2017.
  • Over the past 5 years, Cogent Biosciences' Preferred Stock Liabilities peaked at $110.9 million during FY2020, and registered a low of $77.2 million during FY2017.
  • For the 1-year period, Cogent Biosciences' Preferred Stock Liabilities averaged around $110.9 million, with its median value being $110.9 million (2020).